AstraZeneca Ends Volrustomig Trial for First-Line Metastatic NSCLC Pulmonology Advisor 14:23 Fri, 21 Aug
Osimertinib/Savolitinib Improves Survival in MET-Driven EGFRm NSCLC Pulmonology Advisor 16:31 Wed, 19 Aug
DESTINY-Lung04: First-Line Trastuzumab Deruxtecan Improves PFS in NSCLC Pulmonology Advisor 16:31 Wed, 19 Aug
Zipalertinib Plus Chemo Improves PFS in Advanced EGFR Ex20ins NSCLC Pulmonology Advisor 15:02 Tue, 18 Aug
BlossomHill Wins FDA Fast Track For Bh-30643 In EGFR-Mutant Nsclc;Stock Up RTT News 13:31 Tue, 18 Aug
Enhertu Scores In NSCLC, Advancing AstraZeneca’s And Daiichi’s Growth Strategies Scrip Pharma Intelligence 22:30 Mon, 17 Aug
AstraZeneca axes NSCLC trial after bispecific deemed unlikely to best Keytruda Clinical Trials Arena 15:52 Mon, 17 Aug
Daiichi Sankyo And AstraZeneca's Phase 3 Trial Enhertu Meets Primary Endpoint In HER2 Nsclc RTT News 10:53 Mon, 17 Aug
AZ’s First China Deal Finally Pays Off With Phase III NSCLC Win Scrip Pharma Intelligence 09:36 Mon, 17 Aug
Ivonescimab Plus Chemotherapy Approved for First-Line Squamous Nsclc; HARMONi-6 Establishes New Gold Standard in Lung Cancer Treatment PR Newswire (Press Release) 13:21 Wed, 12 Aug
Opdivo gains Korean approval for perioperative treatment of resectable NSCLC Korea Biomedical Review 07:10 Thu, 06 Aug
Surgical Resection After Immunochemotherapy in NSCLC May Improve Survival Pulmonology Advisor 16:27 Wed, 05 Aug
SKYSCRAPER: Anti-TIGIT/Anti-PD-L1 Antibody Combo Fails to Improve Survival in PD-L1-High NSCLC Oncology Nurse Advisor 15:02 Tue, 04 Aug
Genprex partners with Roche Diagnostics on biomarker validation for NSCLC Verdict Medical Devices 11:20 Tue, 04 Aug
